Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 286,818
  • Shares Outstanding, K 24,919
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,630 K
  • 60-Month Beta 2.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.69
Trade SAVA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.78 +322.30%
on 09/04/20
12.34 -4.88%
on 09/25/20
+8.66 (+281.17%)
since 09/01/20
3-Month
2.78 +322.30%
on 09/04/20
12.34 -4.88%
on 09/25/20
+8.75 (+292.64%)
since 07/01/20
52-Week
1.05 +1,018.10%
on 10/22/19
12.34 -4.88%
on 09/25/20
+10.51 (+854.47%)
since 10/01/19

Most Recent Stories

More News
Cassava Sciences' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Cassava Sciences.

SAVA : 11.48 (-0.26%)
Top Biotech Stocks To Watch Before Friday; 3 Names To Know

3 Biotech Stock Poised For Huge Growth In The Long Run.

JNJ : 148.28 (-0.40%)
MRNA : 69.30 (-2.05%)
SAVA : 11.48 (-0.26%)
VRTX : 271.98 (-0.05%)
AZN : 54.71 (-0.16%)
Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

AZN : 54.71 (-0.16%)
PFE : 36.41 (-0.79%)
GILD : 62.93 (-0.41%)
IMMU : 85.29 (+0.31%)
MRNS : 12.37 (-3.74%)
PTH : 136.27 (+0.26%)
WVE : 8.28 (-2.47%)
BBC : 39.01 (+0.08%)
BTEC : 47.54 (-0.25%)
NVUS : 0.9500 (unch)
SAVA : 11.48 (-0.26%)
IDNA : 39.01 (+0.13%)
IBBJ : 26.18 (+0.58%)
Cassava Sciences (SAVA) in Focus: Stock Moves 8.5% Higher

Cassava Sciences (SAVA) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

ALDX : 7.28 (-1.75%)
SAVA : 11.48 (-0.26%)
Add Value to Your Portfolio With 5 High Earnings Yield Picks

If other factors are constant while comparing stocks, the one with a higher earnings yield has the potential to provide comparatively greater returns.

ALXN : 115.01 (+0.51%)
AVID : 8.37 (-2.22%)
BTG : 6.72 (+3.07%)
CURO : 7.11 (+0.85%)
SAVA : 11.48 (-0.26%)
Could This Be the Medical Breakthrough for The Next Decade

, /PRNewswire/ -- A new medical development is sweeping the country. Some may see it as controversial - but the studies don't lie. It's effective. So effective, in fact, that the FDA has just fast-tracked...

SAGE : 59.79 (-2.18%)
SAVA : 11.48 (-0.26%)
APTO : 6.06 (+1.00%)
AEZS : 0.3530 (+0.57%)
CRHM : 2.16 (-0.46%)
Company News for Apr 24, 2020

Companies In The News Are: LLY, SAVA, FLR, LYTS

LLY : 145.96 (-1.39%)
FLR : 9.06 (+2.84%)
LYTS : 6.60 (-2.22%)
SAVA : 11.48 (-0.26%)
What Lies Ahead for Cassava Sciences (SAVA) in Q4 Earnings?

During the Q4 investors' call, Cassava Sciences (SAVA) is likely to provide an update on its lead candidate PT-125, which is being developed for the treatment of Alzheimer's disease.

AVEO : 5.84 (-1.68%)
CCXI : 54.95 (+0.27%)
SAVA : 11.48 (-0.26%)
HARP : 16.25 (-4.36%)
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences

The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences

AIRI : 1.2200 (unch)
DERM : 18.75 (+0.05%)
AGRX : 2.98 (-1.97%)
MBOT : 7.84 (+2.62%)
SAVA : 11.48 (-0.26%)
Buy Multibagger Stocks as Odds of a Rally Are High in 2020

Multibagger stocks can make most of the bull run, courtesy of strong fundamentals and businesses that can multiply in a short span of time.

AIRI : 1.2200 (unch)
DERM : 18.75 (+0.05%)
AGRX : 2.98 (-1.97%)
MBOT : 7.84 (+2.62%)
SAVA : 11.48 (-0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

2nd Resistance Point 12.56
1st Resistance Point 12.04
Last Price 11.48
1st Support Level 11.09
2nd Support Level 10.66

See More

52-Week High 12.34
Last Price 11.48
Fibonacci 61.8% 8.03
Fibonacci 50% 6.70
Fibonacci 38.2% 5.36
52-Week Low 1.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar